JPWO2022093374A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022093374A5 JPWO2022093374A5 JP2023525023A JP2023525023A JPWO2022093374A5 JP WO2022093374 A5 JPWO2022093374 A5 JP WO2022093374A5 JP 2023525023 A JP2023525023 A JP 2023525023A JP 2023525023 A JP2023525023 A JP 2023525023A JP WO2022093374 A5 JPWO2022093374 A5 JP WO2022093374A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- compound
- acid residues
- pharma
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105678P | 2020-10-26 | 2020-10-26 | |
| US63/105,678 | 2020-10-26 | ||
| US202163193753P | 2021-05-27 | 2021-05-27 | |
| US63/193,753 | 2021-05-27 | ||
| PCT/US2021/047827 WO2022093374A1 (en) | 2020-10-26 | 2021-08-26 | Compounds,compositions and methods of use to treat spinal fusions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023547889A JP2023547889A (ja) | 2023-11-14 |
| JP2023547889A5 JP2023547889A5 (https=) | 2024-09-02 |
| JPWO2022093374A5 true JPWO2022093374A5 (https=) | 2024-09-02 |
Family
ID=81383097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525023A Pending JP2023547889A (ja) | 2020-10-26 | 2021-08-26 | 脊椎融合を治療するための化合物、組成物、および使用の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230390363A1 (https=) |
| EP (1) | EP4232075A4 (https=) |
| JP (1) | JP2023547889A (https=) |
| AU (1) | AU2021369193A1 (https=) |
| CA (1) | CA3196688A1 (https=) |
| MX (1) | MX2023004829A (https=) |
| WO (1) | WO2022093374A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019232285A1 (en) | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| WO2022093373A1 (en) * | 2020-10-26 | 2022-05-05 | Purdue Research Foundation | Compounds,compositions and methods of use to treat bone fractures |
| EP4719459A1 (en) * | 2023-06-01 | 2026-04-08 | Radius Health, Inc. | Methods for identification and quantitation of abaloparatide and related peptide impurities |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018102616A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| EP3765488A1 (en) * | 2018-03-12 | 2021-01-20 | Fresenius Kabi iPSUM S.r.l. | Process for the manufacture of pthrp analogue |
| WO2019232285A1 (en) * | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| WO2022093373A1 (en) * | 2020-10-26 | 2022-05-05 | Purdue Research Foundation | Compounds,compositions and methods of use to treat bone fractures |
-
2021
- 2021-08-26 WO PCT/US2021/047827 patent/WO2022093374A1/en not_active Ceased
- 2021-08-26 CA CA3196688A patent/CA3196688A1/en active Pending
- 2021-08-26 EP EP21887114.3A patent/EP4232075A4/en active Pending
- 2021-08-26 AU AU2021369193A patent/AU2021369193A1/en active Pending
- 2021-08-26 MX MX2023004829A patent/MX2023004829A/es unknown
- 2021-08-26 US US18/033,658 patent/US20230390363A1/en active Pending
- 2021-08-26 JP JP2023525023A patent/JP2023547889A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023029957A (ja) | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 | |
| JP5908000B2 (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| CN105934257B (zh) | 用于含氮和羟基的药物的生物可逆引入基团 | |
| RU2007122804A (ru) | Меченные радиоактивным изотопом конъюгаты rgd-содержащих пептидов и способы их получения с помощью click-химии | |
| JP2010031018A5 (https=) | ||
| CN1181760A (zh) | 亲脂性肽类激素衍生物 | |
| RU2019112897A (ru) | Комбинаторная терапия с агонистами cnp контролируемого высвобождения | |
| JP2023029957A5 (https=) | ||
| EA009366B1 (ru) | Связанные с полиэтиленгликолем соединения гпп-1 | |
| JP2020511459A5 (https=) | ||
| EA020613B1 (ru) | Цитотоксические конъюгаты с соединением, связывающим рецептор нейропептида y | |
| JP2024506435A (ja) | 化合物、組成物、および骨折を処置するための使用方法 | |
| CN110139665A (zh) | 包含其中骨组织选择性肽与甲状旁腺激素(pth)或其片段结合的融合肽的药物组合物和生物材料 | |
| JP2023547889A (ja) | 脊椎融合を治療するための化合物、組成物、および使用の方法 | |
| JPWO2022093374A5 (https=) | ||
| JP2012500284A (ja) | ペプチド性ｐｔｈ受容体アゴニスト | |
| JPWO2021148501A5 (https=) | ||
| JPWO2022093373A5 (https=) | ||
| PT866861E (pt) | Clonagem molecular e caracterizacao de moleculas relacionadas com relaxina e com a familia dos ligandos da insulina | |
| CN116801900A (zh) | 用于治疗骨折的化合物、组合物和使用方法 | |
| RU94023808A (ru) | Пептиды, обладающие регенеративно-репаративным действием | |
| CN116710068A (zh) | 用于治疗脊柱融合的化合物、组合物和方法 | |
| RU2009146017A (ru) | Способы мечения | |
| WO2024057793A1 (ja) | 癌転移を抑制するシトルリン化ペプチド | |
| JPWO2020109978A5 (https=) |